SCHEMBL7055807

SCHEMBL7055807

COc1cc2c(C(C)CNC=O)c[nH]c2c(Cl)c1Cl

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTNR1A P48039 4/20 0.47
MTNR1B P49286 4/20 0.47
PDE3B Q13370 2/20 0.33
PDE3A Q14432 2/20 0.33
ADRB3 P13945 4/20 0.32
ADRB1 P08588 3/20 0.32
ADRB2 P07550 2/20 0.32
HTR2B P41595 2/20 0.32
HTR2A P28223 1/20 0.32
HTR2C P28335 1/20 0.32
TRPV1 Q8NER1 1/20 0.31
ALDH1A1 P00352 2/20 0.31
HTT P42858 1/20 0.31
MEN1 O00255 1/20 0.30
LMNA P02545 1/20 0.30
CYP1A2 P05177 1/20 0.30
CYP3A4 P08684 1/20 0.30
CYP2D6 P10635 1/20 0.30
CYP2C9 P11712 1/20 0.30
NFKB1 P19838 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4966587 0.83 MTNR1A (0.69) MTNR1AMTNR1BHTR2BTRPV1MEN1
SCHEMBL7058302 0.83 MTNR1A (0.42) MTNR1AMTNR1BPDE3BPDE3AHTR2B
SCHEMBL7055344 0.81 MTNR1A (0.54) MTNR1AMTNR1BHTR2CTRPV1
SCHEMBL9672887 0.81 HTR2A (0.49) MTNR1AMTNR1BPDE3BPDE3AHTR2B
SCHEMBL8822729 0.78 MTNR1A (0.45) MTNR1AMTNR1BHTR2BMEN1LMNA
SCHEMBL8822760 0.77 MTNR1A (0.60) MTNR1AMTNR1BHTR2BHTR2CTRPV1
SCHEMBL7053288 0.77 MTNR1A (0.52) MTNR1AMTNR1BHTR2BHTR2AHTR2C
SCHEMBL8822694 0.76 MTNR1A (0.39) MTNR1AMTNR1B
SCHEMBL7055207 0.75 MTNR1A (0.36) MTNR1AMTNR1BPDE3BPDE3A
SCHEMBL7055930 0.75 MTNR1A (0.37) MTNR1AMTNR1BHTR2BHTR2AHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0656209-B1 Melatonin derivatives for use in treating desynchronization disorders LILLY CO ELI (US) 2003-05-07 EP disclosed
EP-0655243-B1 Melatonin derivatives for use in treating sleep disorders LILLY CO ELI (US) 2002-08-21 EP disclosed
US-6180657-B1 SLEEP DISORDERS ELI LILLY AND COMPANY 2001-01-30 US disclosed
US-5770610-A ADMINISTERING R-(+)-N-(2-METHYL-2-(5-METHOXY-6-CHLOROINDOL-3-YL)ETHYL) ACETAMIDE ELI LILLY AND COMPANY (US) 1998-06-23 US disclosed
US-5654325-A Melatonin derivatives for use in treating sleep disorders ELI LILLY AND COMPANY (US) 1997-08-05 US disclosed
EP-0748627-A2 Melatonin agonists for use in the treatment of benign prostatic hyperplasia ELI LILLY AND COMPANY (US) 1996-12-18 EP disclosed
EP-0656209-A2 Melatonin derivatives for use in treating desynchronization disorders ELI LILLY AND COMPANY (US) 1995-06-07 EP disclosed
EP-0655243-A2 Melatonin derivatives for use in treating sleep disorders ELI LILLY AND COMPANY (US) 1995-05-31 EP disclosed
US-4997845-A β-alkylmelatonins as ovulation inhibitors ELI LILLY AND COMPANY (US) 1991-03-05 US disclosed